| Stage | SCI | % of rev | WW | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $162M | 100.00% | SCI ×6.82 |
| Gross profit | $272M | 24.59% | $114M | 70.32% | WW +45.7pp |
| Operating income | $253M | 22.84% | $9M | 5.84% | SCI +17.0pp |
| Pre-tax income | $189M | 17.05% | $3M | 1.80% | SCI +15.3pp |
| Net income | $141M | 12.76% | $14M | 8.67% | SCI +4.1pp |
| Stage | SCI | WW | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $162M100.00% | SCI ×6.82 |
| Gross profit | 24.59%$272M | 70.32%$114M | WW +45.7pp |
| Operating income | 22.84%$253M | 5.84%$9M | SCI +17.0pp |
| Pre-tax income | 17.05%$189M | 1.80%$3M | SCI +15.3pp |
| Net income |
| 12.76%$141M |
| 8.67%$14M |
| SCI +4.1pp |
No disclosed counterparties: SCI, WW.